Lead and manganese levels in serum and erythrocytes in Alzheimer's disease and mild cognitive impairment: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

We examined serum and erythrocyte lead and manganese levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL), which contains over 1000 registrants including over 200 cases of Alzheimer's disease (AD) and 100 mildly cognitively impaired (MCI) individuals. After correcting for confounding effects of age, collection site and sex, we found a significant decrease in serum manganese levels in AD subjects compared to healthy controls. Analysis of smaller subset of erythrocytes revealed no difference in either lead or manganese levels in AD. Although lead and manganese have neurotoxic effects and may be involved in AD pathology, our results showed that neither metal in serum nor erythrocytes are suitable biomarkers in our cohort. However, prospective studies might reveal whether the burden of either metal modifies disease outcomes.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Metallomics

Title: Metallomics : integrated biometal science

Publisher: Royal Society of Chemistry (RSC)

ISSN (Electronic): 1756-591X

ISSN (Print): 1756-5901

Publication date (Electronic): Jun 01 2016

Volume: 8

Issue: 6

Affiliations

[1 ] Elemental Bio-imaging Facility, University of Technology Sydney, Broadway, New South Wales, Australia. dominic.hare@uts.edu.au and The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia. ashley.bush@florey.edu.au.

[2 ] The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia. ashley.bush@florey.edu.au and IBM Research - Australia, Carlton, Victoria, Australia.

[3 ] The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia. ashley.bush@florey.edu.au and Cooperative Research Centre for Mental Health, Carlton South, Victoria, Australia.

[4 ] The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia. ashley.bush@florey.edu.au.

[5 ] Cooperative Research Centre for Mental Health, Carlton South, Victoria, Australia and The School of Medical Sciences, Edith Cowan University, Joondalup, Western Australia, Australia and The McCusker Alzheimer's Research Foundation, Hollywood Private Hospital, Nedlands, Western Australia, Australia and The Centre of Excellence for Alzheimer's Disease Research and Care, Edith Cowan University, Joondalup, Western Australia, Australia.

Article

DOI: 10.1039/c6mt00019c

PubMed ID: 26962965

SO-VID: 2aa9fc4b-dbf7-4a95-b92e-80d5df4b0a67

History

Data availability:

Comments

Comment on this article

scite_

Cited by 16

See all cited by